Item
Caffeine Anhydrous (CAFIN)
The composition of Caffeine is 98.5%~101.0%.
Sweetener
Attributes
- Gluten-free
- Halal
- Ingredient declaration
- Kosher
- Ready-to-Eat (RTE)
- Vegan
- Non-GMO
Locations
| Location name | Address |
|---|---|
| CSPC Innovation Pharmaceutical Co., Ltd. | No. 62 Zhangju Road Luancheng County Shijiazhuang City, Hebei Province 050000 CHN |
| Fuller Enterprise USA Inc. | 1735 E. Grevillea Ct. Ontario, CA 91761 |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| CoA Sample | CSPC Innovation Pharmaceutical Co., Ltd. | 1032107114.pdf | 7/28/2021 | 7/28/2023 |
| Allergens | Fuller Enterprise USA Inc. | Allergens.pdf | 6/24/2020 | 6/24/2022 |
| Allergens | CSPC Innovation Pharmaceutical Co., Ltd. | Allergens.pdf | 9/14/2022 | 9/13/2024 |
| CoA Sample | Fuller Enterprise USA Inc. | B012005027.pdf | 4/7/2022 | 4/6/2024 |
| BSE - TSE | CSPC Innovation Pharmaceutical Co., Ltd. | BSETSE Statement.pdf | 1/5/2021 | 1/5/2024 |
| BSE - TSE | Fuller Enterprise USA Inc. | BSETSE Statement.pdf | 1/5/2021 | 1/5/2024 |
| Label Sample | Fuller Enterprise USA Inc. | Caffeine Label Example.JPG | 4/7/2022 | 4/7/2023 |
| Ingredient Statement | CSPC Innovation Pharmaceutical Co., Ltd. | Composition Statement.pdf | 1/14/2021 | 1/14/2022 |
| Ingredient Statement | Fuller Enterprise USA Inc. | Composition Statement.pdf | 1/14/2021 | 1/14/2022 |
| Country of Origin | Fuller Enterprise USA Inc. | Country of Origin.pdf | 5/19/2020 | 5/19/2023 |
| Country of Origin | CSPC Innovation Pharmaceutical Co., Ltd. | Country of Origin.pdf | 9/15/2022 | 9/14/2025 |
| Dietary Supplement Questionnaire | CSPC Innovation Pharmaceutical Co., Ltd. | Dietary Supplement Questionnaire.pdf | 6/30/2022 | 6/30/2023 |
| Dietary Supplement Questionnaire | Fuller Enterprise USA Inc. | Dietary Supplement Questionnaire.pdf | 5/19/2020 | 5/19/2021 |
| Gluten | Fuller Enterprise USA Inc. | GlutenFreeStatement.pdf | 1/14/2021 | 1/14/2022 |
| GRAS/NDI/ODI Statement | CSPC Innovation Pharmaceutical Co., Ltd. | GRAS Statement.pdf | 10/20/2020 | 10/20/2023 |
| HACCP | Fuller Enterprise USA Inc. | HACCP PLAN--HACCP.pdf | 4/7/2022 | 4/6/2025 |
| HACCP Process Flow Diagram | Fuller Enterprise USA Inc. | HACCP Plan - Flow Chart.pdf | 4/7/2022 | 4/6/2024 |
| HACCP Process Flow Diagram | CSPC Innovation Pharmaceutical Co., Ltd. | HACCP Plan.pdf | 6/30/2022 | 6/29/2024 |
| Halal | CSPC Innovation Pharmaceutical Co., Ltd. | Halal - 2027.03.14.pdf | 3/15/2023 | 3/14/2027 |
| Halal | Fuller Enterprise USA Inc. | Halal Certificate - 20230112.pdf | 1/12/2023 | |
| 3rd Party Audit Certificate | CSPC Innovation Pharmaceutical Co., Ltd. | ISO22000 - 2023.09.15.pdf | 9/16/2020 | 9/15/2023 |
| Kosher | Fuller Enterprise USA Inc. | Kosher - 20220831.pdf | 8/31/2022 | |
| Kosher | CSPC Innovation Pharmaceutical Co., Ltd. | Kosher Certificate - 2023.08.31.pdf | 8/28/2022 | 8/31/2023 |
| Lot Code | CSPC Innovation Pharmaceutical Co., Ltd. | Lot NumberStatement.pdf | 1/14/2021 | 1/14/2024 |
| Lot Code | Fuller Enterprise USA Inc. | Lot NumberStatement.pdf | 1/14/2021 | 1/14/2024 |
| Safety Data Sheet (SDS) | CSPC Innovation Pharmaceutical Co., Ltd. | MSDS.pdf | 5/20/2020 | 5/20/2023 |
| Safety Data Sheet (SDS) | Fuller Enterprise USA Inc. | MSDS.pdf | 5/20/2020 | 5/20/2023 |
| No Animal Ingredient Statement | CSPC Innovation Pharmaceutical Co., Ltd. | Non-Animal Origin Statement.pdf | 8/16/2021 | 8/16/2022 |
| EtO Statement | CSPC Innovation Pharmaceutical Co., Ltd. | Non-ETOand Non-Chemical Sterilization Statement.pdf | 2/19/2020 | 2/18/2022 |
| GMO | CSPC Innovation Pharmaceutical Co., Ltd. | Non-GMO Statement.pdf | 1/14/2021 | 1/14/2023 |
| GMO | Fuller Enterprise USA Inc. | Non-GMO Statement.pdf | 1/14/2021 | 1/14/2023 |
| Irradiation Status Statement | CSPC Innovation Pharmaceutical Co., Ltd. | Non-IrradiatedStatement.pdf | 1/14/2021 | 1/14/2023 |
| Irradiation Status Statement | Fuller Enterprise USA Inc. | Non-IrradiatedStatement.pdf | 1/14/2021 | 1/14/2023 |
| Item Questionnaire | Fuller Enterprise USA Inc. | NotApplicable_ItemQuestionnaire.pdf | 2/10/2023 | 2/9/2026 |
| Natural | Fuller Enterprise USA Inc. | NotApplicable_Natural.pdf | 4/7/2022 | 4/7/2023 |
| Organic | CSPC Innovation Pharmaceutical Co., Ltd. | NotApplicable_Organic.pdf | 12/29/2021 | -- |
| Organic | Fuller Enterprise USA Inc. | NotApplicable_Organic.pdf | 4/7/2022 | -- |
| Nutrition | Fuller Enterprise USA Inc. | Nutrition.pdf | 6/24/2020 | 6/24/2023 |
| Pesticide | CSPC Innovation Pharmaceutical Co., Ltd. | Pesticide Free Statement.pdf | 11/17/2020 | 11/17/2022 |
| Pesticide | Fuller Enterprise USA Inc. | Pesticide Free Statement.pdf | 11/17/2020 | 11/17/2022 |
| Phthalate Esters Letter | CSPC Innovation Pharmaceutical Co., Ltd. | Phthalates Free Statement.pdf | 5/8/2021 | 5/8/2022 |
| California Prop. 65 | CSPC Innovation Pharmaceutical Co., Ltd. | Prop 65 Statement.pdf | 2/24/2021 | 2/24/2023 |
| California Prop. 65 | Fuller Enterprise USA Inc. | Prop 65 Statement.pdf | 2/24/2021 | 2/24/2023 |
| Residual Statement | CSPC Innovation Pharmaceutical Co., Ltd. | Residual Solvent Solvent Used Statement.pdf | 1/14/2021 | 1/14/2022 |
| Residual Statement | Fuller Enterprise USA Inc. | Residual Solvent Solvent Used Statement.pdf | 1/14/2021 | 1/14/2022 |
| Product Specification Sheet | CSPC Innovation Pharmaceutical Co., Ltd. | Specification.pdf | 12/15/2021 | 12/14/2024 |
| Product Specification Sheet | Fuller Enterprise USA Inc. | SpecificationUSP41.pdf | 2/20/2020 | 2/19/2023 |
| Suitability Requirements | Fuller Enterprise USA Inc. | Suitability Requirements.pdf | 5/20/2020 | 5/20/2023 |
| Suitability Requirements | CSPC Innovation Pharmaceutical Co., Ltd. | Suitability Requirements.pdf | 9/20/2022 | 9/19/2025 |
| WADA/NSF/NFL Statement | Fuller Enterprise USA Inc. | WADA Statement.pdf | 1/14/2021 | 1/14/2023 |
